866-997-4948(US-Canada Toll Free)

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

Published By :

Transparency Market Research

Published Date : Aug 2012

Category :


No. of Pages : 74 Pages

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood. CTC technology offers advantages like high sensitivity, high specificity, reproducible, repeatable, and non-invasive diagnostic assay for guiding treatment decision and improved patient triage. Circulatory tumor cells (CTC) are cancer cells that get separated from the primary tumor or its metastases that circulate in the peripheral blood. Metastasis the major cause of cancer deaths and CTC may constitute seeds from metastases and indicate the spread of diseases. The circulating tumor cells' analysis will allow early detection of metastasis when it is less invasive. Molecular characterization of CTC enables the treatment to be planned effectively. Removing CTC from the blood will limit metastases after surgery or therapy.

Molecular characterization is significant from the point of view of developing new methodologies for CTC detection, isolation, enumeration, and subsequent genetic or proteomic analysis. Advancement in medical technologies is allowing efficient removal of CTC from circulation and has therapeutic potential.

This research report analyzes the Circulating tumor cells and cancer stem cells market from a technical as well as business perspective, describing the overall market size, industry growth rate, and market trends. It gives an analysis of the recent developments in CTC and CSC markets and includes detailed profiles of top industry players along with Porter’s five force analysis. The report also analyzes all the micro and macro factors essential for the existing market players and new entrants along. 

Major regions covered under this research study are North America, Europe, the Asia-Pacific, and the Rest of the World.

Reasons to Buy this Report
  • This research report will provide a forward perspective on market issues affecting market growth rate
  • It will help in understanding the competitive environment and make accurate and informed business decisions to withstand competition
  • The report will provide pin-point analysis of changing competition dynamics to keep one ahead of competitors
  • It will provide an in-depth analysis of key product segments and robust product segments
  • The research report provides a seven-year forecast on business projections and segmental behavior
Table Of Contents

1. Introduction
1.1. Key Objectives
1.2. Report Description
1.3. Scope and Definitions
1.4. Research Methodology

2. Executive Summary

3. Market Overview
3.1. Overview of Global Diagnostic Market
3.2. SWOT Analysis of Diagnostic Industry
3.3. Current Status of the Cancer Diagnostic Market
3.4. Overview of CTC and CSC
3.4.1. Current Status of the Market
3.4.2. Future Potential
3.4.3. Growth Opportunities
3.5. Recent Breakthrough in CTC and CSC Research
3.6. Drivers for CTC and CSC Market
3.7. Restraints for CTC and CSC Market
3.8. Opportunities for CTC and CSC Market
3.9. Market Trend and Recent Developments

4. Circulating Tumor Cells (CTC)
4.1. Biology of CTC
4.2. Characteristics of CTC 
4.3. CTC for Cancer Diagnostics
4.4. Current Approaches for CTC Detection
4.4.1. Circulating Tumor Cell Separation System
4.4.2. High Throughput Cell Sorter (FACS)
4.4.3. CellSearch System 
4.4.4. CTC Chip
4.4.5. Microfluidics
4.4.6. Emerging Approaches
4.4.7. Competitive Analysis of Different CTC Detection Approaches Advantages and Disadvantages of CTC Analysis Approaches Innovation and Advancements Qualitative Analysis of CTC Detection Approaches
4.5. Penetrance of Various Surface Markers for CTC
4.6. CTC Market by Detection Classes
4.6.1. CTC Prostate: Market Size and Potential
4.6.2. CTC Breast: Market Size and Potential
4.6.3. CTC Colon: Market Size and Potential
4.6.4. CTCPancreas: Market Size and Potential
4.6.5. CTC Urine: Market Size and Potential

5. Cancer Stem Cells (CSC)
5.1. Biology of CSC
5.2. Markers for CSC
5.3. Surface Markers for CSC
5.4. Targeted Therapies
5.5. Intracellular Signaling Pathways Studied Currently in the CSC Space
5.6. Quantitative Methods Used for Detecting CSC
5.7. CSC Market Size and Potential

6. Competitive Analysis
6.1. Analysis of Research and Development Activity in CSC and CTC Space
6.2. Vendors and their investment in R&D
6.3. Strategic Analysis of Investment Opportunities in the Market
6.3.1. Return on Investment Opportunity
6.3.2. SWOT Analysis of Major Players
6.3.3. Cost of Market Entry
6.3.4. Positive Market Trends
6.3.5. Negative Market Trends
6.3.6. Patents in the CTC and CSC Space
6.3.7. Regulation and Barriers

7. Geographic Overview
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. ROW (Rest of the World)

8. Company Profiles
8.1. Abbott Laboratories
8.1.1. Company Overview
8.1.2. Product Profile
8.1.3. Growth Strategy
8.1.4. Recent Development
8.1.5. SWOT Analysis
8.2. Bristol-Myers Squibb (BMS)
8.2.1. Company Overview
8.2.2. Product Profile
8.2.3. Growth Strategy
8.2.4. Recent Development
8.2.5. SWOT Analysis
8.3. Dexcom
8.3.1. Company Overview
8.3.2. Product Profile
8.3.3. Growth Strategy
8.3.4. Recent Development
8.3.5. SWOT Analysis
8.4. Eli Lilly
8.4.1. Company Overview
8.4.2. Product Profile
8.4.3. Growth Strategy
8.4.4. Recent Development
8.4.5. SWOT Analysis
8.5. GlaxoSmithKline
8.5.1. Company Overview
8.5.2. Product Profile
8.5.3. Growth Strategy
8.5.4. Recent Development
8.5.5. SWOT Analysis
8.6. Glenmark Pharmaceuticals
8.6.1. Company Overview
8.6.2. Product Profile
8.6.3. Growth Strategy
8.6.4. Recent Development
8.6.5. SWOT Analysis
8.7. Johnson & Johnson
8.7.1. Company Overview
8.7.2. Product Profile
8.7.3. Growth Strategy
8.7.4. Recent Development
8.7.5. SWOT Analysis
8.8. Lupin
8.8.1. Company Overview
8.8.2. Product Profile
8.8.3. Growth Strategy
8.8.4. Recent Development
8.8.5. SWOT Analysis
8.9. Roche
8.9.1. Company Overview
8.9.2. Product Profile
8.9.3. Growth Strategy
8.9.4. Recent Development
8.9.5. SWOT Analysis
8.10.1. Company Overview
8.10.2. Product Profile
8.10.3. Growth Strategy
8.10.4. Recent Development
8.10.5. SWOT Analysis

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *